IL7 and neoplasm: We found that combination therapy-improved tumour rejection by promoting T-cell infiltration into tumours, proliferation and polyfunctionality of tumour-infiltrating lymphocytes (TILs), and expansion of endogenous memory T cells, which are mediated by the interdependent loop between IL-7 and IFN-γ signalling in T cells.